Immediate Impact

59 standout
Sub-graph 1 of 23

Citing Papers

Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Advances in diagnosis and treatment of bladder cancer
2024 Standout
2 intermediate papers

Works of Melissa Hamilton being referenced

Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 Trial
2022
Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial
2022

Author Peers

Author Last Decade Papers Cites
Melissa Hamilton 493 285 83 84 35 691
Ying X. Gue 571 149 58 65 62 798
Dinara Makenbaeva 319 130 79 25 46 590
Francis Cajfinger 335 508 15 84 17 640
Mika Skeppholm 573 262 17 42 23 714
Karl Tornyos 112 211 32 110 20 630
Ariel Cohen 485 70 37 220 44 723
Tommy Chung 421 355 13 117 27 677
Nicholas Sicignano 235 144 25 79 37 699
Nikhil Chauhan 245 206 13 84 31 590
Mustafa Öztürk 320 63 17 54 47 585

All Works

Loading papers...

Rankless by CCL
2026